Atovaquone/Proguanil Bgr

Atovaquone/Proguanil Bgr is a combination medication used for malaria prevention and treatment. It contains Atovaquone and Proguanil Hydrochloride, effective against malaria-causing parasites.

Atovaquone/Proguanil Bgr is primarily used for the prevention and treatment of malaria, a disease caused by parasites transmitted through mosquito bites. This medication is often prescribed for travelers visiting areas where malaria is common. It works by interfering with the growth of parasites in the red blood cells, helping to control and prevent the spread of the disease.

Common effects of Atovaquone/Proguanil Bgr may include nausea, vomiting, diarrhea, and stomach pain. Some users might experience headache, dizziness, or cough. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Atovaquone/Proguanil Bgr should be used with caution in individuals with severe kidney or liver problems. It is important to follow the prescribed dosage and complete the full course of treatment. This medication should be stored at room temperature, away from moisture and heat.

Atovaquone/Proguanil Bgr may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited while using this medication.